SG
Sudhir Gurlingayya Nanjannavar
About Sudhir Gurlingayya Nanjannavar
Data last updated:
Sudhir Gurlingayya Nanjannavar is a Director at Vista Infinity Pharma Private Limited (since 2024) and Partner at Belret Pharma Limited Liability Partnership (since 2021). The companies operate in Chemicals.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vista Infinity Pharma Private Limited U10794KA2024PTC195377 | Director | 28 Nov 2024 | 2024 | Active | |
| Partner | 27 Sep 2021 | 2021 | Active |
Board colleagues of Sudhir Gurlingayya Nanjannavar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vikrant Vilas Shanbhag | 10853393 | Vista Infinity Pharma Private Limited | Director |
| Mahesh Ramangouda Patil | 09334881 | Belret Pharma Limited Liability Partnership | Designated Partner |
| Shailendra Dharanendra Jain | 02405931 | Belret Pharma Limited Liability Partnership | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudhir Gurlingayya Nanjannavar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudhir Gurlingayya Nanjannavar
Sudhir Gurlingayya Nanjannavar currently holds 2 directorships: Vista Infinity Pharma Private Limited (Director, since 28 Nov 2024); Belret Pharma Limited Liability Partnership (Partner, since 27 Sep 2021).
Sudhir Gurlingayya Nanjannavar was first appointed on 27 Sep 2021 as Partner at Belret Pharma Limited Liability Partnership. The most recent appointment on record is 28 Nov 2024 at Vista Infinity Pharma Private Limited.
The current boards of Sudhir Gurlingayya Nanjannavar's companies include Vikrant Vilas Shanbhag (Vista Infinity Pharma Private Limited), Mahesh Ramangouda Patil (Belret Pharma Limited Liability Partnership), Shailendra Dharanendra Jain (Belret Pharma Limited Liability Partnership).